Weyel D A, Schaffer R B
Toxicol Appl Pharmacol. 1985 Mar 15;77(3):427-33. doi: 10.1016/0041-008x(85)90182-6.
The use of isocyanates in industry has been increasing and, therefore, the potential for human exposure has also increased. Two such isocyanates are diphenylmethane-4,4'-diisocyanate (MDI) and dicyclohexylmethane-4,4'-diisocyanate (SMDI). Furthermore, there are only a few reports describing the toxicity of these diisocyanates. The pulmonary irritation of the aromatic isocyanate MDI and the sensory and pulmonary irritation of the cycloaliphatic isocyanate SMDI were studied in an animal bioassay. Groups of male, Swiss-Webster mice were exposed to aerosol concentrations of MDI varying from 17 to 67 mg/m3. The total exposure time for both isocyanates was 240 min, and the respiratory patterns and frequency of four mice were recorded during each exposure. Concentrations of MDI and SMDI in the exposure chamber were determined gravimetrically. The mass median aerodynamic diameter (MMAD) and geometric standard deviation for the MDI aerosol were 0.7 micron and 1.6 and for the SMDI aerosol were 0.9 micron and 1.5, respectively. The inhalation responses during the 4-hr exposures to aerosols of MDI and SMDI were investigated, and the animal model was used to determine time-response and concentration-response relationships for all exposures. From these results it was determined that the level of effect was dependent on both the duration of exposure and the exposure concentration. Unlike many other isocyanates tested with this animal model, MDI and SMDI acted primarily as pulmonary irritants, evoking little or no sensory irritation. The concentrations required to reduce the respiratory rate 50% (RD50) due to pulmonary irritation was 32 mg/m3 for MDI and 40 mg/m3 for SMDI. Increases in lung weight were found in groups of animals killed 24 hr following all exposures to MDI and SMDI. Using the animal model, which has been calibrated to human responses with nitrogen dioxide and other pulmonary irritants, the recommended TLV-TWAs for MDI and SMDI in industry should be no higher than 0.3 and 0.4 mg/m3, respectively.
工业上异氰酸酯的使用一直在增加,因此,人类接触的可能性也随之增加。二苯基甲烷-4,4'-二异氰酸酯(MDI)和二环己基甲烷-4,4'-二异氰酸酯(SMDI)就是这样两种异氰酸酯。此外,关于这些二异氰酸酯毒性的报道很少。在一项动物生物测定中研究了芳香族异氰酸酯MDI的肺部刺激性以及脂环族异氰酸酯SMDI的感官和肺部刺激性。将雄性瑞士韦伯斯特小鼠分组,暴露于浓度为17至67毫克/立方米的MDI气溶胶中。两种异氰酸酯的总暴露时间均为240分钟,每次暴露期间记录四只小鼠的呼吸模式和频率。通过重量法测定暴露室内MDI和SMDI的浓度。MDI气溶胶的质量中值空气动力学直径(MMAD)和几何标准差分别为0.7微米和1.6,SMDI气溶胶的分别为0.9微米和1.5。研究了4小时暴露于MDI和SMDI气溶胶期间的吸入反应,并使用该动物模型确定所有暴露的时间-反应和浓度-反应关系。从这些结果可以确定,效应水平取决于暴露持续时间和暴露浓度。与用该动物模型测试的许多其他异氰酸酯不同,MDI和SMDI主要起肺部刺激物的作用,几乎不会引起或根本不会引起感官刺激。由于肺部刺激使呼吸频率降低50%(RD50)所需的浓度,MDI为32毫克/立方米,SMDI为40毫克/立方米。在所有暴露于MDI和SMDI后24小时处死的动物组中发现肺重量增加。使用已根据二氧化氮和其他肺部刺激物的人体反应进行校准的动物模型,工业上MDI和SMDI的推荐时间加权平均容许浓度(TLV-TWA)应分别不高于0.3和0.4毫克/立方米。